Spectral AI Stock Falls 12% Despite Winning FDA's De Novo Classification For Its DeepView System
26/5 17:28
(RTTNews) - Shares of Spectral AI, Inc. (MDAI) are falling about 12 percent in Tuesday morning trading after the company announced that the U.S. Food and Drug Administration granted De Novo Classification for its DeepView System, which is used in burn care in various settings....